anti-F9 antibody product blog
Tags: Antibody; Polyclonal Antibody; anti-F9 antibody;
The F9 f9 (Catalog #MBS2528219) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The F9 Polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s F9 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC).IHC: 1:25-1:100. Researchers should empirically determine the suitability of the F9 f9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The F9 f9 product has the following accession number(s) (GI #80479046) (NCBI Accession #AAI09215.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the F9 Polyclonal Antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human colon cancer tissue using F9 Polyclonal Antibody at dilution 1:45)
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using F9 Polyclonal Antibody at dilution 1:45)
This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease.
Immunogen: Recombinant protein of human F9. Buffer: PBS with 0.05% sodium azide, 50% glycerol, pH7.3. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing F9 are readily searchable from our website. Different antibodies against the same target such as F9 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Liver, Uncharacterized Tissue tissues are correlated with this protein. The following patways have been known to be associated with this gene. F9 also interacts with the following gene(s): F10, F12, GGCX, SERPINC1. Adenocarcinoma, Carcinoma, Hemophilia A, Hemophilia B, Immune System Diseases, Liver Diseases, Liver Neoplasms, Mental Disorders, Necrosis, Vascular Diseases are some of the diseases may be linked to F9 Polyclonal Antibody.